Section 195.418

Title XII PUBLIC HEALTH AND WELFARE

Chapter 195

Effective - 28 Aug 2001, 2 histories, see footnote   (history) 

  *195.418.  Until December 31, 2016 — Limitations on the retail sale of methamphetamine precursor drugs — violations, penalty. — 1.  The retail sale of methamphetamine precursor drugs shall be limited to:

  (1)  Sales in packages containing not more than a total of three grams of one or more methamphetamine precursor drugs, calculated in terms of ephedrine base, pseudoephedrine base and phenylpropanolamine base; and

  (2)  For nonliquid products, sales in blister packs, each blister containing not more than two dosage units, or where the use of blister packs is technically infeasible, sales in unit dose packets or pouches.

  2.  Any person holding a retail sales license pursuant to chapter 144 who knowingly violates subsection 1 of this section is guilty of a class A misdemeanor.

  3.  Any person who is considered the general owner or operator of the outlet where ephedrine, pseudoephedrine, or phenylpropanolamine products are available for sale who violates subsection 1 of this section shall not be penalized pursuant to this section if such person documents that an employee training program was in place to provide the employee with information on the state and federal regulations regarding ephedrine, pseudoephedrine, or phenylpropanolamine.

­­--------

(L. 2001 H.B. 471 merged with S.B. 89 & 37)

*This section was amended by S.B. 491, 2014, effective 1-01-17.  Due to the delayed effective date, both versions of this section are printed here.